No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]
We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]
COPN – the Canadian Osteoporosis Patient Network (COPN) exists today due to the dedication and perseverance of four pioneering women: Sheila Brien, Priscilla Coles, Ina Inse and Gail LeMieux. Since […]
Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]
Since the COVID-19 lockdown began and even now as things begin to open up across the country, many health professionals have been consulting with their patients on-line or on the […]
Latest News Dr. Angela Man-Wei Cheung ISCD 2024 Board Announcement April 19, 2024 The International Society for Clinical Densitometry (ISCD) is the leading membership organization for professionals working to assess, […]
Latest News Nine Drug Formularies In Canada List Evenity® For Reimbursement For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk Of Fracture April 3, 2024 Amgen Canada has […]
Latest News IOF Welcomes Dr. Famida Jiwa as Chair of the Committee of National Societies February 9, 2024 Following the elections held for the position of Chair of the International […]
Latest News Clinical Practice Guideline – Top 2023 Article on CMAJ.ca January 29, 2024 On October 10, 2023 a new guideline on the management of osteoporosis and fracture prevention was […]
